Animal sera, animal sera derivatives and substitutes used in the manufacture of pharmaceuticals, Strasbourg, France, 5-6 May 1998: Meeting report

Biologicals

Volumn 26, Issue 4, 1998, Pages 365-368

  Castle, Peter ^a   Robertson, James S ^b  

^a European Pharmacopoeia   (France)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

BRAIN SPONGIOSIS; CATTLE DISEASE; CELL CULTURE; CONFERENCE PAPER; CONTAMINATION; CULTURE MEDIUM; DISEASE TRANSMISSION; DRUG SYNTHESIS; GAMMA IRRADIATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; SERUM; ULTRAVIOLET IRRADIATION; VIRUS INACTIVATION;

EID: 0032461244     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1006/biol.1998.0165     Document Type: Conference Paper

References (1)

1. 1. Bovine Spongiform Encephalopathy (BSE). WHO Consultation on public health issues related to BSE and the emergence of a new variant of Creutzfeldt-Jakob disease. WHO Weekly Epidemiological Record, 12 April 1996, 71, No. 15, 113-115.